Stage FocusPre-Seed, Seed, Series A, Series B+
GeographyUK, Europe
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
Syncona is not a typical VC — it's a FTSE250-listed company that founds, builds, and funds transformational healthcare companies, with a biotech portfolio valued at £1.2B. The public listing creates an unusual dynamic: shares trade at roughly a 45% discount to net asset value (market cap ~£659M), which means public market investors are effectively getting the portfolio at half price. In 2024/25, S...
Notable Investments
A
AutolusB
Beacon TherapeuticsQ
Quell TherapeuticsR
Resolution TherapeuticsSimilar Funds
CA
Cambridge Angels
Cambridge, United Kingdom
DeepTech NativeBiotechMedtechAdvanced MaterialsPre-SeedSeed
S
SmartGateVC
Yerevan, Armenia
DeepTech NativeBiotechNeurotechAIPre-SeedSeed
CC
Carduso Capital
Groningen, Netherlands
DeepTech NativeBiotechEnergy TechPre-SeedSeed
C
Compound
New York, United States
DeepTech NativeBiotechAIRoboticsPre-SeedSeed
HV
Hadean Ventures
Oslo, Norway
Pure DeepTechBiotechMedtechAIPre-SeedSeed
HV
Hummingbird VC
London, United Kingdom
GeneralistBiotechAIBlockchainPre-SeedSeed